- Home
- ARWR vs XP Comparison
ARWR vs XP Comparison
Compare ARWR & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARWR | XP |
|---|---|---|
| Founded | 2003 | 2001 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 10.9B |
| IPO Year | 2009 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ARWR | XP |
|---|---|---|
| Price | $74.16 | $19.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $83.40 | $23.17 |
| AVG Volume (30 Days) | 1.7M | ★ 5.0M |
| Earning Date | 05-07-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 0.92% |
| EPS Growth | ★ 99.80 | N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $16,142,321.00 | N/A |
| Revenue This Year | N/A | $19.00 |
| Revenue Next Year | N/A | $13.64 |
| P/E Ratio | $335.95 | ★ $11.42 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.44 | $15.51 |
| 52 Week High | $76.76 | $23.13 |
Technical Indicators
Market Signals| Indicator | ARWR | XP |
|---|---|---|
| Relative Strength Index (RSI) | 68.98 | 48.29 |
| Support Level | $60.60 | $18.58 |
| Resistance Level | $76.44 | $20.42 |
| Average True Range (ATR) | 3.01 | 0.76 |
| MACD | 0.99 | -0.03 |
| Stochastic Oscillator | 86.51 | 39.45 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.